CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state-of-the art production facilities.

News Releases

News Releases

CV Sciences, Inc. Reports Second Quarter 2016 Financial Results

LAS VEGAS, NV–(Marketwired – August 12, 2016) – CV Sciences, Inc. (CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today its financial results for the second quarter and six months ended June 30, 2016. Second Quarter 2016 – Business Highlights Drug Development Program. Following the CanX Acquisition in December 2015, CV Sciences commenced